Abstract PD2-2: Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer

Richard Bell, Julia Brown, Mahesh Parmar, Mark Toi, Thomas Suter, Guenther Steger, Xavier Pivot, John Mackey, Christian Jackisch, Rebecca Dent, Peter Hall, Almut Mecke, Leilani Morales, Louise Provencher, Elzbieta Staroslawska, Roberto Hegg, Laurence Vanlemmens, Andreas Kirsch, Andreas Schneeweiss, Norikazu MasudaFriedrich Overkamp, David Cameron

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)PD2-2-PD2-2
JournalCancer Research
Issue number9 Supplement
Publication statusPublished - 1 May 2015

Cite this